Deschatelets Pascal Insider Trades

Insider Trading History

Track insider trading activity for Deschatelets Pascal. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $1.69M 41,250 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.69M 90,040 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$48.3M 1,177,222 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$25.2M 614,836 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $48.3M 1,177,222 shares
Last Trade
Jan 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 25,840 shares
$21.63
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $47.2M 1,151,382 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$129k 5,928 shares
$21.77
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $47.5M 1,157,310 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$18k 909 shares
$19.79
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $47.5M 1,158,219 shares
Last Trade
Jan 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$50.5k 2,277 shares
$22.19
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $3.38M 82,500 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.6M 82,500 shares
$19.39
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
May 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$223k 12,780 shares
$17.42
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $47.6M 1,160,496 shares
Last Trade
May 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$223k 12,780 shares
$17.42
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $47.1M 1,147,716 shares
Last Trade
Jan 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.4k 826 shares
$29.52
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $47.1M 1,148,542 shares
Last Trade
Jan 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$120k 3,948 shares
$30.43
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $47.3M 1,152,490 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$453k 15,045 shares
$30.13
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $46.7M 1,137,445 shares
Last Trade
Jan 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.5k 750 shares
$29.96
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $46.7M 1,138,195 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$65.7k 2,288 shares
$28.70
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $46.8M 1,140,483 shares
Last Trade
May 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 24,500 shares
$43.22
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $524k 12,780 shares
Last Trade
May 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 24,500 shares
$43.22
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $4.46M 108,622 shares
Last Trade
May 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.34M 78,907 shares
$42.30
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $49M 1,194,890 shares
Last Trade
May 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.34M 78,907 shares
$42.30
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Scientific Officer
Holding Value $46.7M 1,138,555 shares
Last Trade
May 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.34M 78,907 shares
$42.35
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up